###begin article-title 0
###xml 27 33 <span type="species:ncbi:10090">Murine</span>
A Detailed Analysis of the Murine TAP Transporter Substrate Specificity
###end article-title 0
###begin p 1
Conceived and designed the experiments: PvE BP. Performed the experiments: LS MK AB EB. Analyzed the data: AS PvE BP YK. Wrote the paper: AS PvE LS BP MK YK AB EB. Other: Performed the computational data analysis: YK BP. Interpreted the results: AS PvE BP.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 293 298 <span type="species:ncbi:9606">human</span>
###xml 304 310 <span type="species:ncbi:10090">murine</span>
###xml 385 391 <span type="species:ncbi:10090">murine</span>
The transporter associated with antigen processing (TAP) supplies cytosolic peptides into the endoplasmic reticulum for binding to major histocompatibility complex (MHC) class I molecules. Its specificity therefore influences the repertoire of peptides presented by MHC molecules. Compared to human TAP, murine TAP's binding specificity has not been characterized as well, even though murine systems are widely used for basic studies of antigen processing and presentation.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 49 55 <span type="species:ncbi:10090">murine</span>
###xml 191 197 <span type="species:ncbi:10090">murine</span>
###xml 286 291 <span type="species:ncbi:9606">human</span>
###xml 296 302 <span type="species:ncbi:10090">murine</span>
###xml 339 345 <span type="species:ncbi:10090">murine</span>
###xml 455 461 <span type="species:ncbi:10090">murine</span>
We performed a detailed experimental analysis of murine TAP binding specificity by measuring the binding affinities of 323 peptides. Based on this experimental data, a computational model of murine TAP specificity was constructed. The model was compared to previously generated data on human and murine TAP specificities. In addition, the murine TAP specificities for known epitopes and random peptides were predicted and compared to assess the impact of murine TAP selectivity on epitope selection.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 668 676 668 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 739 746 739 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 49 54 <span type="species:ncbi:9606">human</span>
###xml 294 299 <span type="species:ncbi:9606">human</span>
###xml 339 345 <span type="species:ncbi:10090">murine</span>
###xml 436 442 <span type="species:ncbi:10090">murine</span>
###xml 474 479 <span type="species:ncbi:9606">human</span>
###xml 493 499 <span type="species:ncbi:10090">Murine</span>
###xml 563 568 <span type="species:ncbi:9606">human</span>
###xml 797 803 <span type="species:ncbi:10090">murine</span>
###xml 921 926 <span type="species:ncbi:10090">mouse</span>
Comparisons to a previously constructed model of human TAP specificity confirms the well-established differences for peptide substrates with positively charged C-termini. In addition these comparisons show that several residues at the N-terminus of peptides which strongly influence binding to human TAP showed little effect on binding to murine TAP, and that the overall influence of the aminoterminal residues on peptide affinity for murine TAP is much lower than for the human transporter. Murine TAP also partly prefers different hydrophobic amino acids than human TAP in the carboxyterminal position. These species-dependent differences in specificity determined in vitro are shown to correlate with the epitope repertoire recognized in vivo. The quantitative model of binding specificity of murine TAP developed herein should be useful for interpreting epitope mapping and immunogenicity data obtained in humanized mouse models.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 186 189 186 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Shastri1">[1]</xref>
###xml 281 284 281 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Swain1">[2]</xref>
###xml 285 288 285 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Bowen1">[4]</xref>
###xml 336 339 336 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Pamer1">[5]</xref>
###xml 340 343 340 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-SalernoGoncalves1">[8]</xref>
###xml 401 404 401 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Choi1">[9]</xref>
###xml 447 448 447 448 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 508 512 508 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Liblau1">[10]</xref>
###xml 535 536 535 536 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 590 597 590 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 651 652 651 652 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 832 836 832 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Sette1">[11]</xref>
###xml 837 841 837 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Pascolo1">[13]</xref>
###xml 558 563 <span type="species:ncbi:9606">human</span>
###xml 680 685 <span type="species:ncbi:9606">human</span>
###xml 686 694 <span type="species:ncbi:9606">patients</span>
###xml 827 831 <span type="species:ncbi:10090">mice</span>
###xml 903 909 <span type="species:ncbi:10090">murine</span>
###xml 914 919 <span type="species:ncbi:9606">human</span>
CD8+ T lymphocytes monitor cells for non-self protein expression by scanning their surface for MHC class I molecules presenting peptides derived from proteins expressed inside the cells [1]. The recognition of peptide epitopes by T cells mediates the clearance of viral infections [2]-[4], controls the growth of intracellular bacteria [5]-[8], and has a role in immunity against some types of cancer [9]. Defects in self tolerance can lead to CD8+ immune responses that contribute to autoimmune pathologies [10]. The importance of CD8+ immune responses for human health has motivated many in vivo studies aiming to identify the peptide targets of CD8+ responses. As studies with human patients are often not ethically feasible and samples can be hard to obtain, many epitope discovery studies have been conducted in humanized mice [11]-[13]. It is therefore important to understand differences between murine and human antigen processing machinery that may affect the identity and immunodominance of HLA class I-restricted peptide epitopes.
###end p 9
###begin p 10
###xml 42 43 42 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 256 260 256 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Seifert1">[14]</xref>
###xml 262 266 262 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Reits1">[15]</xref>
###xml 419 423 419 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Princiotta1">[16]</xref>
###xml 425 429 425 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Fruci1">[17]</xref>
###xml 558 562 558 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Momburg1">[18]</xref>
###xml 563 567 563 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-vanEndert1">[20]</xref>
###xml 719 723 719 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Chang1">[21]</xref>
###xml 832 836 832 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Saveanu1">[22]</xref>
###xml 728 734 <span type="species:ncbi:9606">humans</span>
The majority of peptides recognized by CD8+ T cells are generated through the endogenous MHC-I antigen processing and presentation pathway. Initially proteins in the cytosol are cleaved into peptide fragments by proteasomes, possibly in concert with TPPII [14], [15], and by other proteases. The produced peptides are subject to rapid degradation by cytosolic aminopeptidases, and only approximately 1% of the peptides [16], [17] escape degradation through transport into the ER by the TAP transporters that prefer peptides with a length of 8 to 16 residues [18]-[20]. Inside the ER, peptides are subject to further N-terminal trimming by ERAP1, which efficiently cleaves substrates between 8 and 16 residues in length [21]. In humans, an additional ER aminopeptidase, ERAP2, with a preference for basic residues, complements ERAP1 [22]. Finally, peptides with suitable length and sequence are able to bind empty MHC class I molecules with the help of multiple chaperones forming the MHC class I loading complex. The peptide:MHC complex is then transported to the cell surface through the Golgi apparatus. Sequence specificities at each step in this antigen processing pathway influence what peptides are eventually presented to T cells.
###end p 10
###begin p 11
###xml 207 211 207 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Higgins1">[23]</xref>
###xml 456 460 456 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-vanEndert2">[24]</xref>
###xml 640 644 640 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Neefjes1">[25]</xref>
###xml 884 888 884 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Momburg1">[18]</xref>
###xml 890 894 890 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Koopmann1">[26]</xref>
###xml 896 900 896 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Roelse1">[27]</xref>
###xml 1114 1118 1114 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Reits1">[15]</xref>
###xml 1120 1124 1120 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Herberts1">[28]</xref>
###xml 1257 1261 1257 1261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-vanEndert1">[20]</xref>
###xml 1539 1543 1539 1543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Gromme1">[29]</xref>
###xml 1655 1659 1655 1659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Gubler1">[30]</xref>
###xml 1661 1665 1661 1665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-vanEndert3">[31]</xref>
###xml 1907 1911 1907 1911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Fruci1">[17]</xref>
###xml 2157 2161 2157 2161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Peters1">[32]</xref>
###xml 38 44 <span type="species:ncbi:10090">murine</span>
The focus of the present study is the murine TAP transporter, a heterodimeric complex consisting of the TAP1 and TAP2 proteins, both of which are members of the ATP binding cassette (ABC) transporter family [23]. Peptide transport by TAP is a sequential process initiated by peptide binding to a site probably located at the interface between the cytosol and the transmembrane channel of TAP, followed by ATP dependent transport of the peptide into the ER [24]. Two assays measuring peptide affinity for TAP are available. One of these measures the ATP- and temperature-dependent accumulation of glycosylated transported peptides in the ER [25]. This assay has the advantage of measuring the complete peptide transport process, but may also be affected by the rate of peptide degradation in the cytosol either before transport into the ER, or after retrograde transport out of the ER [18], [26], [27]. While cytosolic peptide degradation is generally extremely rapid, some peptides, for example those with multiple basic residues in the aminoterminal positions, have been found to be more resistant to degradation [15], [28]. A second assay measures only the initial peptide binding step at low temperature, rendering interference by peptidases less likely [20]. While it was theoretically conceivable that some peptides bind TAP but are not transported, which would have rendered the latter assay unreliable, it has been found that addition of very long side chains is required to produce peptides that bind TAP without being transported [29]. Moreover, it has been directly demonstrated that peptide binding affinity reflects peptide transport affinity [30], [31]. Further strong evidence for the biological relevance of the results of TAP binding assays was provided in a study showing that TAP binding affinity paralleled closely the efficiency of epitope presentation by cell surface class I molecules [17]. The fact that an algorithm that is based on the TAP affinity of a large number of peptides measured using the binding assay, ameliorates prediction of naturally processed CTL epitopes represents an additional corroboration of the binding assay [32]
###end p 11
###begin p 12
###xml 10 18 10 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 157 158 157 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 216 220 216 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Schumacher1">[19]</xref>
###xml 222 226 222 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Heemels1">[33]</xref>
###xml 228 232 228 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Momburg2">[34]</xref>
###xml 338 342 338 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Momburg2">[34]</xref>
###xml 639 643 639 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Momburg2">[34]</xref>
###xml 644 648 644 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Neefjes2">[36]</xref>
###xml 809 813 809 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-vanEndert3">[31]</xref>
###xml 815 819 815 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Peters1">[32]</xref>
###xml 821 825 821 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Daniel1">[37]</xref>
###xml 827 831 827 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Uebel1">[38]</xref>
###xml 1172 1176 1172 1176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Daniel1">[37]</xref>
###xml 1279 1283 1279 1283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Momburg1">[18]</xref>
###xml 1284 1288 1284 1288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-vanEndert1">[20]</xref>
###xml 139 145 <span type="species:ncbi:10090">Murine</span>
###xml 150 153 <span type="species:ncbi:10116">rat</span>
###xml 240 245 <span type="species:ncbi:9606">human</span>
###xml 679 684 <span type="species:ncbi:9606">human</span>
The first in vitro studies characterizing the sequence specificity of TAP peptide transport focused mainly on C-terminal peptide residues. Murine and rat cimb TAP molecules prefer peptides with hydrophobic C-termini [19], [33], [34], while human TAP molecules transport efficiently peptides with hydrophobic and basic C-terminal residues [34]. Additional studies of the influence of the aminoterminal and internal peptide sequence, carried out using the peptide transport assay, concluded that these positions have little effect on TAP affinity, with the exception of Pro residues in several positions which decreased transport efficiency [34]-[36]. However, detailed studies of human TAP specificity using the peptide-binding assay elucidated a significant influence of the three N-terminal peptide residues [31], [32], [37], [38]. The same preferences are found in peptides of different lengths for the first three N-terminal and the C-terminal positions. This makes it likely that peptide binding to TAP involves two contact sites at the free peptide ends, with each having a defined binding preference, while the connecting residues can form loops of variable lengths [37]. This model would also explain why there is a minimal peptide length required for efficient transport [18]-[20].
###end p 12
###begin p 13
###xml 91 97 <span type="species:ncbi:10090">murine</span>
###xml 102 107 <span type="species:ncbi:9606">human</span>
###xml 245 250 <span type="species:ncbi:9606">human</span>
###xml 336 342 <span type="species:ncbi:10090">murine</span>
In summary, while past studies with model substrates have demonstrated differences between murine and human TAP specificity, subsequent large-scale studies that allow for the development of general quantitative prediction models have focused on human TAP alone. In this study, we have therefore characterized the binding specificity of murine TAP with a large panel of peptides, allowing for a detailed comparison between the transport preferences in the two species. We have further utilized this data to build a predictive model of TAP transport for peptides of any length, which can be applied to identify likely epitopes or their precursors.
###end p 13
###begin title 14
Results
###end title 14
###begin title 15
###xml 17 23 <span type="species:ncbi:10090">murine</span>
Establishing the murine TAP binding assay
###end title 15
###begin p 16
###xml 194 198 194 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-vanEndert1">[20]</xref>
###xml 525 529 525 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-vanEndert1">[20]</xref>
###xml 544 547 544 547 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 550 558 550 558 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1</bold>
###xml 550 558 550 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002402-g001"><bold>Figure 1</bold></xref>
###xml 594 597 594 597 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 716 717 716 717 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 771 772 771 772 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</sub>
###xml 894 895 894 895 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 921 925 921 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-vanEndert1">[20]</xref>
###xml 72 77 <span type="species:ncbi:9606">human</span>
###xml 312 318 <span type="species:ncbi:10090">murine</span>
###xml 657 662 <span type="species:ncbi:10090">mouse</span>
###xml 843 848 <span type="species:ncbi:9606">human</span>
###xml 933 938 <span type="species:ncbi:10090">mouse</span>
###xml 1085 1090 <span type="species:ncbi:9606">human</span>
We previously established an assay measuring competition for binding to human TAP complexes, over-expressed in insect cells, between a radio-labeled reporter peptide and unlabeled test peptides [20]. In this study, standard procedures were utilized to produce recombinant baculoviruses driving expression of the murine TAP1 and TAP2 transporter subunits, as confirmed by immunoblot analysis (not shown). Formation of TAP1/TAP2 complexes able to bind peptides was measured using peptide R9L (RRYNASTEL) as a standard reporter [20], labeled with 125I. Figure 1 shows a Scatchard plot analysis of 125I-R9L binding to microsomes from Sf9 cells co-infected with mouse TAP1 and TAP2 viruses. This experiment indicates 8x106 binding-competent TAP complexes per Sf9 cell, and a KD of 400 nM for the reporter peptide. Previously established values for human TAP complexes expressed in Sf9 cells are 1x106 and 390 nM, respectively [20]. Thus, mouse TAP complexes are expressed with very high efficiency in our insect cell system, and bind the standard reporter peptide with the same affinity as human TAP complexes.
###end p 16
###begin title 17
###xml 17 23 <span type="species:ncbi:10090">murine</span>
Establishing the murine TAP binding assay.
###end title 17
###begin p 18
###xml 45 48 45 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 77 83 <span type="species:ncbi:10090">murine</span>
###xml 269 275 <span type="species:ncbi:10090">murine</span>
Panel A depicts a Scatchard plot analysis of 125I-labeled peptide binding to murine TAP1/TAP2 complexes. The lower panels depict dilution series determining the optimal concentrations for (B) the fluorescent reporter peptide and (C) the volume of microsomes expressing murine TAP. Maximal specific binding, as measured by the polarization reading (y-axis), is achieved at 20 nM reporter peptide and 10 microl of microsomes.
###end p 18
###begin p 19
###xml 352 356 352 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-vanEndert1">[20]</xref>
###xml 748 756 744 752 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1</bold>
###xml 748 756 744 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002402-g001"><bold>Figure 1</bold></xref>
###xml 416 422 <span type="species:ncbi:10090">murine</span>
Using the same insect cell system for TAP expression, a novel assay was established which is based on detecting fluorescence polarization rather than the activity of a radioactive tracer. A reporter peptide was synthesized in which position 6 (Ser) of peptide R9L was substituted by a Cys residue coupled to a fluorescein group (R9L-FITC). As expected [20], this peptide did not bind to microsomes containing either murine TAP1 or TAP2 protein alone (data not shown). To establish a fluorescence polarization assay, we determined the concentrations of reporter peptide and microsomes yielding the highest specific binding signal (mP reading). Optimal results were obtained with a peptide concentration of 20 nM and a microsome volume of 10 microl (Figure 1).
###end p 19
###begin p 20
###xml 0 7 0 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002402-t001">Table 1</xref>
###xml 232 238 <span type="species:ncbi:10090">murine</span>
Table 1 shows an example of assay results, with five peptides at each end of the range of affinities measured in the assay. Measured relative affinities range over more than five logs. As expected from previous characterizations of murine TAP specificity, many peptides with very low affinities have a C-terminal Lys residue, while high affinity peptides have a hydrophobic C-terminus.
###end p 20
###begin title 21
###xml 28 34 <span type="species:ncbi:10090">murine</span>
Highest and lowest measured murine TAP affinities
###end title 21
###begin p 22
###xml 55 60 <span type="species:ncbi:10090">mouse</span>
###xml 274 279 <span type="species:ncbi:10090">mouse</span>
Thus, the combination of very high-level expression of mouse TAP complexes in Sf9 microsomes, and high affinity binding of the reporter peptide R9L-FITC to these complexes, allowed us to establish a highly efficient novel binding assay for characterizing the specificity of mouse TAP transporters. Of note, this assay not only avoids the use of radioactive tracers but also is significantly faster than our previous assay since microsome washing for removal of free peptide ligand is not required.
###end p 22
###begin p 23
###xml 105 110 <span type="species:ncbi:9606">human</span>
###xml 171 176 <span type="species:ncbi:9606">human</span>
The fluorescence polarization assay was validated by comparing data obtained using insect cell-expressed human TAP complexes and reporter peptide R9L-FITC (which binds to human TAP with identical affinity), with data previously generated in the radioligand binding assay. These experiments showed that peptide affinities determined in the two assays were within the margin of experimental error of each other (data not shown).
###end p 23
###begin title 24
###xml 46 52 <span type="species:ncbi:10090">murine</span>
Selecting and testing peptides for binding to murine TAP
###end title 24
###begin p 25
###xml 47 53 <span type="species:ncbi:10090">murine</span>
###xml 195 201 <span type="species:ncbi:10090">murine</span>
We selected and tested peptides for binding to murine TAP binding in a two-stage process. In the first stage, we selected a set of 198 peptides 9 residues in length, which included several known murine T cell epitopes and other peptides chosen from natural protein sequences. These peptides were chosen so to ensure that all amino acids were represented at all nine positions in at least two peptides of the dataset.
###end p 25
###begin p 26
###xml 95 99 95 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Buus1">[39]</xref>
###xml 101 105 101 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Udaka1">[40]</xref>
###xml 512 514 512 514 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 615 617 615 617 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 769 777 769 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002402.s001">Table S1</xref>
In the second stage, we selected a set of peptides using a "query by committee" (QBC) approach [39], [40], which should minimize any holes in knowledge left after the first set. Briefly, five prediction models were generated, each based on randomly drawn 80% of the current binding data. These five models were used to predict the binding affinity of 50,000 peptides of length nine. Thirty-three peptides were chosen that had an at least 25-fold difference between the highest and lowest of the five predicted IC50 values. Such peptides represent likely holes in knowledge, because no robust prediction for their IC50 value was determined from the initial set of peptides. In total, we determined the binding affinities of 231 peptides of length 9, which are listed in Table S1.
###end p 26
###begin title 27
###xml 53 59 <span type="species:ncbi:10090">murine</span>
Establishing a predictive model for 9-mer binding to murine TAP
###end title 27
###begin p 28
###xml 460 478 460 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Material &amp; Methods</xref>
###xml 1057 1065 1057 1065 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2</bold>
###xml 1057 1065 1057 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002402-g002"><bold>Figure 2</bold></xref>
###xml 1209 1210 1209 1210 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1314 1316 1314 1316 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 85 91 <span type="species:ncbi:10090">murine</span>
###xml 200 206 <span type="species:ncbi:10090">murine</span>
###xml 1402 1408 <span type="species:ncbi:10090">murine</span>
We utilized the set of measured binding affinities to generate a prediction model of murine TAP specificity, and evaluated its accuracy. The SMM-BP algorithm was used to determine a scoring matrix of murine TAP specificity. Briefly, the algorithm determines the matrix by minimizing the difference between measured and predicted affinities, while preferring matrices that assign similar scores to amino acids known to have similar binding characteristics (see Material & Methods). To evaluate the quality of the binding prediction, we used 5-fold cross validation: the peptides were randomly partitioned into 5 mutually exclusive subsets. For the validation, one of the 5 subsets was used as the test set and the other 4 subsets were combined to form a training set. A prediction was generated using only peptides from the training set, and used to predict the affinity of all peptides in the blind set. Repeating this process 5 times gives one affinity prediction for each peptide in the original set, which can be compared to its known measured affinity. Figure 2 depicts the results of the cross validation. The linear correlation between measured and predicted affinities was highly significant (Pearson r2 = 0.52, p<0.0001). 85% of the peptides had a measured affinity within 10-fold range of the predicted IC50 value. In conclusion, we have established a matrix model of 9-mer peptide binding to murine TAP that correlates well with measured affinities in a blinded evaluation.
###end p 28
###begin title 29
Assessing prediction quality through cross-validation.
###end title 29
###begin p 30
Each point in the scatterplot represents one peptide. For each peptide, the measured affinity (x-axis) is plotted against the predicted affinity (y-axis). The predicted values were obtained in a blinded 5-fold cross-validation.
###end p 30
###begin p 31
###xml 118 127 118 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002402-g003">Figure 3a</xref>
###xml 491 495 491 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-vanEndert3">[31]</xref>
###xml 611 615 611 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Schumacher1">[19]</xref>
###xml 617 621 617 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Momburg2">[34]</xref>
###xml 762 766 762 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Momburg2">[34]</xref>
###xml 768 772 768 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Neefjes2">[36]</xref>
###xml 958 962 958 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Neefjes2">[36]</xref>
###xml 1152 1156 1152 1156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Neefjes2">[36]</xref>
###xml 75 81 <span type="species:ncbi:10090">murine</span>
###xml 160 166 <span type="species:ncbi:10090">murine</span>
###xml 432 438 <span type="species:ncbi:10090">murine</span>
###xml 481 486 <span type="species:ncbi:9606">human</span>
###xml 564 570 <span type="species:ncbi:10090">murine</span>
###xml 1211 1217 <span type="species:ncbi:10090">murine</span>
Next, we examined the influence of specific peptide residues on binding to murine TAP determined in our matrix model. Figure 3a shows the prediction matrix for murine TAP that assigns a score to each residue in a 9-mer peptide. The scores approximate the contribution to binding free energy of the corresponding peptide residue. Residues at peptide positions 1, 2, 3 and 9 (the C-terminus) have the greatest influence on binding to murine TAP, similar to previous observations for human TAP [31]. At the C-terminus, hydrophobic residues are the most preferred for murine TAP, in agreement with previous reports [19], [34]. At positions 1,2 and 3, the most notable impact on binding is the strong negative influence of proline which had also been reported before [34], [36]. The remaining matrix entries with significant scores (R2, D3, F3, Y3, D4 and Y8) were not singled out as influential residues in the one study looking at the impact of those positions [36]. This is likely due to their lower impact compared to the C-terminal and Proline residues, as well as the fact that several residues including D and R were missing from the panel tested in [36]. Overall, the specificity matrix calculated by us for murine TAP is in good qualitative agreement with previously published experimental data generated with model substrates.
###end p 31
###begin title 32
###xml 23 29 <span type="species:ncbi:10090">murine</span>
###xml 34 39 <span type="species:ncbi:9606">human</span>
Binding specificity of murine and human TAP.
###end title 32
###begin p 33
###xml 57 63 <span type="species:ncbi:10090">murine</span>
###xml 74 79 <span type="species:ncbi:9606">human</span>
The matrices were generated from peptide binding data to murine (left) or human (right) TAP molecules. Each column in the matrix corresponds to a position in a peptide of length 9, and each row to a certain residue. Negative values (marked in green for x<-0.5) correspond to residues with higher affinities, while positive values (marked in red for x>0.5) correspond to lower affinities. Matrix positions that differ by more than 0.55 between the two species are boxed.
###end p 33
###begin p 34
###xml 216 220 216 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Peters1">[32]</xref>
###xml 222 230 222 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002402-g003">Figure 3</xref>
###xml 621 625 621 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Momburg2">[34]</xref>
###xml 627 631 627 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Momburg3">[41]</xref>
###xml 78 84 <span type="species:ncbi:10090">murine</span>
###xml 89 94 <span type="species:ncbi:9606">human</span>
###xml 128 134 <span type="species:ncbi:10090">murine</span>
###xml 187 192 <span type="species:ncbi:9606">human</span>
###xml 534 539 <span type="species:ncbi:9606">human</span>
###xml 548 554 <span type="species:ncbi:10090">murine</span>
###xml 733 739 <span type="species:ncbi:10090">murine</span>
###xml 785 790 <span type="species:ncbi:9606">human</span>
###xml 822 827 <span type="species:ncbi:9606">human</span>
###xml 917 923 <span type="species:ncbi:10090">murine</span>
###xml 969 974 <span type="species:ncbi:9606">human</span>
###xml 1035 1041 <span type="species:ncbi:10090">murine</span>
###xml 1084 1089 <span type="species:ncbi:9606">human</span>
###xml 1191 1196 <span type="species:ncbi:9606">human</span>
###xml 1201 1207 <span type="species:ncbi:10090">murine</span>
In order to identify residue positions contributing to the difference between murine and human TAP specificity, we compared the murine matrix scores with those of a previously determined human TAP specificity matrix [32]. Figure 3 depicts the two matrices side by side, and identifies residues with absolute score differences above 0.55 with a bold border. The most drastic difference between matrix scores was observed for Lysine (K) and Arginine (R) at the C-terminus. This corresponds to the previously described finding that only human but not murine TAP complexes can bind peptides with positively charged C-termini [34], [41]. Methionine (M) and Tryptophane (W) are strongly preferred residues for binding at the C-terminus of murine TAP, while they have little or no effect for human TAP. Moreover, compared to the human TAP matrix, the charged residues D and E are essentially neutral in positions 1 and 2 of murine TAP, whereas they clearly inhibit binding to human TAP. Finally, Proline (P) at position 3 disrupts binding to murine TAP while being essential neutral for the human transporter. In summary, although the relative weight of the aminoterminal positions differs between human and murine TAP (see below), binding affinity for both depends mainly on the three N-terminal and the C-terminal residues of a peptide. While the two transporters share many preferences, there are a number of residues with clearly distinct binding patterns.
###end p 34
###begin p 35
###xml 101 106 <span type="species:ncbi:9606">human</span>
###xml 111 116 <span type="species:ncbi:10090">mouse</span>
###xml 122 127 <span type="species:ncbi:10090">Mouse</span>
###xml 217 222 <span type="species:ncbi:9606">human</span>
###xml 247 252 <span type="species:ncbi:9606">human</span>
###xml 361 366 <span type="species:ncbi:10090">mouse</span>
Next we examined the overall importance of C-terminal and N-terminal peptide residues for binding to human and mouse TAP. Mouse TAP has strong preferences or aversion for 13 of 20 amino acids at the C-terminus, while human has only 7. Conversely, human TAP shows preferences or aversion for 16 amino acids in positions 1 to 3 (6 in P1, 4 in P2, 6 in P3), while mouse TAP displays only 7 (1 in P1, 2 in P2, 4 in P3). At the C-terminus, this difference is statistically significant when comparing the absolute coefficient values (p = 0.030, Mann-Whitney Test). For the three N-terminal residues, the p value is 0.062, just slightly above the customary cutoff of p = 0.05.
###end p 35
###begin p 36
###xml 162 167 <span type="species:ncbi:9606">human</span>
###xml 172 177 <span type="species:ncbi:10090">mouse</span>
###xml 218 223 <span type="species:ncbi:9606">human</span>
###xml 358 364 <span type="species:ncbi:10090">murine</span>
###xml 533 539 <span type="species:ncbi:10090">murine</span>
###xml 614 619 <span type="species:ncbi:9606">human</span>
To quantify the relative impact of N-terminal residues and the C-terminus with a single number, we calculated the ratio of standard deviations for the scores for human and mouse TAP at the corresponding positions. For human TAP, the standard deviation of the C terminal scores is 0.59 and 0.41 at the N-terminus, which gives a ratio of 1.4. In contrast, for murine TAP the standard deviation at the C-terminus is 0.82 and 0.31 at the N-terminus, corresponding to a ratio of 2.6 which is nearly twice as high. Overall this shows that murine TAP selects its ligands much more on the basis of the C terminus than its human counterpart.
###end p 36
###begin title 37
Predicting peptide binding for varying lengths
###end title 37
###begin p 38
###xml 542 550 542 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002402.s001">Table S1</xref>
###xml 550 553 550 553 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">). </bold>
###xml 553 561 553 561 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4</bold>
###xml 553 561 553 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002402-g004"><bold>Figure 4</bold></xref>
###xml 823 824 823 824 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1055 1056 1055 1056 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1204 1212 1204 1212 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4</bold>
###xml 1204 1212 1204 1212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002402-g004"><bold>Figure 4</bold></xref>
###xml 1212 1213 1212 1213 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">,</bold>
###xml 1316 1317 1316 1317 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 184 189 <span type="species:ncbi:9606">human</span>
###xml 530 536 <span type="species:ncbi:10090">murine</span>
###xml 670 675 <span type="species:ncbi:9606">human</span>
###xml 683 689 <span type="species:ncbi:10090">murine</span>
###xml 795 801 <span type="species:ncbi:10090">murine</span>
###xml 1133 1138 <span type="species:ncbi:9606">human</span>
###xml 1235 1240 <span type="species:ncbi:9606">human</span>
###xml 1431 1437 <span type="species:ncbi:10090">murine</span>
###xml 1452 1458 <span type="species:ncbi:10090">murine</span>
###xml 1507 1512 <span type="species:ncbi:9606">human</span>
As TAP is known to transport precursor peptides longer than nine residues into the ER, we examined if we could predict their affinity using an approach we had previously developed for human TAP. This was based on representing peptides of any length by their three N-terminal residues plus their one C-terminal residue, and assigning them a binding score based on matrix columns 1, 2, 3 and 9 of the matrix for 9-mer peptides. To evaluate this approach, we first tested a set of 92 peptides with length 8, 10 and 11 for binding to murine TAP (Table S1). Figure 4 shows scatterplots of the predicted versus measured affinities for each of these peptides, using either the human or the murine matrices as predictors. The correlation between prediction and measurement is highly significant for the murine matrix predictions (r2 = 0.58, p<0.01), even slightly above the correlation determined above in cross-validation using 9-mers alone. The results for individual peptide sets are similar, with 8-mers, 10-mers and 11-mers having correlations coefficients r2 of 0.53, 0.67 and 0.64, respectively. In addition, we have compared how the human TAP matrix would have performed on this peptide set. As shown in Figure 4, predictions based on human TAP data would have correlated very poorly with the experimental results (r2 = 0.21). Overall, this confirms that our approach can be used to predict peptide binding for multiple lengths to murine TAP, and that murine TAP has a distinct binding pattern from that of human TAP.
###end p 38
###begin title 39
Prediction quality for peptides of varying lengths.
###end title 39
###begin p 40
###xml 125 131 <span type="species:ncbi:10090">murine</span>
###xml 189 195 <span type="species:ncbi:10090">murine</span>
###xml 278 283 <span type="species:ncbi:9606">human</span>
Each scatterplot represents predicted vs. measured affinities for the set of 8, 10 and 11-mer peptides tested for binding to murine TAP. The predictions on the left plot were made with the murine TAP prediction matrix, the one in the right plot using the previously established human TAP matrix.
###end p 40
###begin title 41
Prediction of T-cell recognition
###end title 41
###begin p 42
###xml 194 195 194 195 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 202 203 202 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 277 281 277 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Kotturi1">[42]</xref>
###xml 283 287 283 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Moutaftsi1">[43]</xref>
###xml 580 581 580 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 584 585 584 585 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 588 589 588 589 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 592 593 592 593 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 599 600 599 600 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 823 831 823 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002402-g005">Figure 5</xref>
###xml 1072 1074 1072 1074 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 23 29 <span type="species:ncbi:10090">murine</span>
###xml 204 208 <span type="species:ncbi:10090">mice</span>
###xml 248 262 <span type="species:ncbi:10245">Vaccinia virus</span>
###xml 1210 1216 <span type="species:ncbi:10090">murine</span>
###xml 1320 1324 <span type="species:ncbi:10090">mice</span>
Next, we tested if our murine TAP transport predictions could identify which peptides contained in a pathogen are recognized as T cell epitopes. As a test set, we used epitopes identified in H-2b or H-2d mice following viral infections with LCM or Vaccinia virus (described in [42], [43] and Oseroff, manuscript submitted). As T cell priming during infection requires processing and presentation of peptides in infected target cells, peptides that are recognized post infection are presumed to be at least permissible for TAP transport. A total of 139 epitopes restricted by H-2 Db, Kb, Dd, Kd and Ld were included in this set, including 34 8-mers, 96 9-mers, 6 10-mers and 3 11-mers. For each virus, we predicted the TAP affinity of all 8, 9, 10 and 11mer peptides that can be derived from their viral source proteins. In Figure 5, these predicted affinities are compared for peptides recognized as T cell epitopes and non-epitopes. As expected, T cell epitopes showed markedly higher TAP affinities than non-epitopes. For example, 43% of all epitopes have a predicted IC50 <10 nM, while only 14% of non-epitope peptides have a similar high affinity. Overall, this confirms that a peptide with high predicted murine TAP affinity has an increased probability of being recognized by T cells following viral infections in mice.
###end p 42
###begin title 43
Utilizing TAP transport predictions to identify T cell epitopes.
###end title 43
###begin p 44
###xml 151 158 151 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Methods</xref>
###xml 14 18 <span type="species:ncbi:11623?0.9953846153846154">LCMV</span>
###xml 126 130 <span type="species:ncbi:10090">mice</span>
###xml 180 186 <span type="species:ncbi:10090">murine</span>
###xml 441 447 <span type="species:ncbi:10090">murine</span>
###xml 452 457 <span type="species:ncbi:9606">human</span>
###xml 491 497 <span type="species:ncbi:10090">murine</span>
###xml 551 557 <span type="species:ncbi:10090">murine</span>
###xml 594 599 <span type="species:ncbi:9606">human</span>
Peptides from LCMV and VACV were classified into either epitopes or non-epitopes depending on their recognition by T cells in mice post infection (see Methods). In the left panel, murine TAP affinity predictions were made for all peptides. At varying cutoffs, the cumulative percentage of epitope and non-epitope peptides that have an affinity of at least the cutoff is given. In the right panel, an ROC plot is used to directly compare the murine and human predictions. The curve made with murine TAP predictions is consistently better at separating murine epitopes from non-epitopes than the human one.
###end p 44
###begin p 45
###xml 438 446 438 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002402-g005">Figure 5</xref>
###xml 51 56 <span type="species:ncbi:9606">human</span>
###xml 61 67 <span type="species:ncbi:10090">murine</span>
###xml 132 137 <span type="species:ncbi:9606">human</span>
###xml 142 148 <span type="species:ncbi:10090">murine</span>
###xml 220 226 <span type="species:ncbi:10090">murine</span>
###xml 266 270 <span type="species:ncbi:10090">mice</span>
###xml 307 312 <span type="species:ncbi:9606">human</span>
###xml 414 420 <span type="species:ncbi:10090">murine</span>
###xml 505 511 <span type="species:ncbi:10090">murine</span>
###xml 551 557 <span type="species:ncbi:10090">murine</span>
###xml 590 595 <span type="species:ncbi:9606">human</span>
###xml 639 643 <span type="species:ncbi:10090">mice</span>
We tested if the differences we identified between human and murine TAP specificity influences the epitope repertoire recognized by human and murine T cells. If this is indeed the case, the correlation between predicted murine TAP affinity and T cell recognition in mice should be higher than for predicted human TAP affinity. We utilized ROC curves to directly compare the ability of both predictions to identify murine T cell epitopes (Figure 5), which clearly demonstrated superior performance for the murine TAP prediction. This confirms that the murine TAP predictions are superior to human ones at identifying epitopes recognized in mice.
###end p 45
###begin p 46
###xml 143 147 143 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Peters1">[32]</xref>
###xml 264 267 264 267 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 384 392 380 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002402-g005">Figure 5</xref>
###xml 416 419 412 415 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 181 187 <span type="species:ncbi:10090">murine</span>
###xml 646 651 <span type="species:ncbi:9606">human</span>
###xml 732 738 <span type="species:ncbi:10090">murine</span>
###xml 864 870 <span type="species:ncbi:10090">murine</span>
###xml 994 998 <span type="species:ncbi:10090">mice</span>
For human TAP, we had previously shown that taking the transport of epitope precursors into account can greatly improve the prediction quality [32]. We applied the same approach to murine TAP by averaging the score of precursor peptides up to a maximal extension Nmax, and assigning a weighting factor alpha. We tested the performance of these predictions on the same dataset used in Figure 5 for varying values of Nmax and alpha. The prediction performance was only marginally improved, below the threshold for statistical significance for all parameter combinations. Thus, the previously established approach to improve epitope predictions for human TAP by including the transport of precursors was not successful when applied to murine TAP and the prediction of viral epitopes. This demonstrates that the predominant influence of C-terminal peptide residues on murine TAP affinity reduces the impact of different N-terminally prolonged precursors being transported on epitope recognition in mice.
###end p 46
###begin title 47
Discussion
###end title 47
###begin p 48
###xml 473 477 473 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Schumacher1">[19]</xref>
###xml 479 483 479 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Momburg2">[34]</xref>
###xml 485 489 485 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Neefjes2">[36]</xref>
###xml 44 50 <span type="species:ncbi:10090">murine</span>
###xml 209 215 <span type="species:ncbi:10090">murine</span>
###xml 463 469 <span type="species:ncbi:10090">murine</span>
###xml 835 841 <span type="species:ncbi:10090">murine</span>
We here presented a large-scale analysis of murine TAP specificity obtained using TAP binding assays. The quantitative binding affinity of 231 9-mer peptides was determined, and used to computationally derive murine TAP specific scoring matrices. The resulting specificity pattern is in good agreement with previous publications that used peptide substitution libraries to directly compare different residues in one position on the affinity or transport rates of murine TAP[19], [34], [36]. In addition, the present study provides the first quantitative specificity data for over seventy residue/position combinations not covered by published substation library data. This complete coverage ensures that no residue/position combination that strongly influences binding has been overlooked, which is necessary to quantitatively predict murine TAP binding specificity for any peptide sequence.
###end p 48
###begin p 49
###xml 677 681 677 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Momburg2">[34]</xref>
###xml 683 687 683 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Neefjes2">[36]</xref>
###xml 43 48 <span type="species:ncbi:9606">human</span>
###xml 53 59 <span type="species:ncbi:10090">murine</span>
###xml 183 188 <span type="species:ncbi:9606">human</span>
###xml 228 234 <span type="species:ncbi:10090">murine</span>
###xml 377 383 <span type="species:ncbi:10090">murine</span>
###xml 436 441 <span type="species:ncbi:9606">human</span>
###xml 478 484 <span type="species:ncbi:10090">murine</span>
###xml 509 514 <span type="species:ncbi:9606">human</span>
We took advantage of being able to compare human and murine TAP specificity matrices, and found that several residues at the N-terminus of peptides that strongly influence binding to human TAP showed little effect on binding to murine TAP. This includes a complete lack of any residue with a strong positive effect on binding in position 1. In contrast, for peptide C-termini, murine TAP is more specific in its binding preference than human TAP. Taken together, we showed that murine TAP is more skewed than human TAP towards binding peptides based on their C-terminus alone. While not reported as significant in the original publications, examining the figures in references [34], [36] supports such a conclusion.
###end p 49
###begin p 50
###xml 207 215 207 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 265 272 265 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 35 40 <span type="species:ncbi:9606">human</span>
###xml 45 51 <span type="species:ncbi:10090">murine</span>
###xml 166 172 <span type="species:ncbi:10090">murine</span>
###xml 331 335 <span type="species:ncbi:10090">mice</span>
###xml 340 345 <span type="species:ncbi:9606">human</span>
The differences discovered between human and murine TAP binding specificity were shown to correlate with differences in the ability to predict epitope recognition in murine hosts. This demonstrates that our in vitro studies correlate with antigen processing events in vivo. It also reinforces that studies of epitope repertoire in mice and human need to take differences between their TAP transporters into account.
###end p 50
###begin p 51
###xml 535 540 <span type="species:ncbi:9606">human</span>
###xml 590 596 <span type="species:ncbi:10090">murine</span>
As TAP is known to transport epitope precursors up to a length of about 16 residues, it is important to characterize its substrate specificity for varying lengths. We were able to successfully predict the affinity of peptides between 8 and 11 residues in length by modeling their binding interaction at the C terminus and the three N terminal residues. In this model of binding, the connecting residues 4 to C-1 of longer peptides are assumed to make only weak interactions with the TAP molecules. This model was previously applied to human TAP, and is shown for the first time to apply to murine TAP as well.
###end p 51
###begin p 52
###xml 660 664 660 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Peh1">[44]</xref>
###xml 990 994 990 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Lauvau1">[45]</xref>
###xml 19 25 <span type="species:ncbi:10090">murine</span>
###xml 202 208 <span type="species:ncbi:9606">humans</span>
###xml 217 232 <span type="species:ncbi:10090">transgenic mice</span>
###xml 543 547 <span type="species:ncbi:10090">mice</span>
###xml 579 584 <span type="species:ncbi:9606">human</span>
###xml 607 613 <span type="species:ncbi:10090">murine</span>
###xml 691 696 <span type="species:ncbi:10090">mouse</span>
###xml 701 706 <span type="species:ncbi:9606">human</span>
The description of murine TAP specificity provides one crucial component towards explaining species specific differences in epitope recognition, which could explain differences in epitope repertoire in humans and HLA transgenic mice frequently used in epitope discovery and vaccine development studies. These data likely will have to be complemented by other studies directed at understanding the impact of other components of the antigen processing pathway that are known to differ between the two species. This includes the lack of ERAP2 in mice, and incompatibilities between human MHC molecules and the murine peptide loading complex (specifically tapasin [44]). Also, the difference in mouse and human self, which, due to the requirement for self-tolerance, leads to differences in TCR repertoire, may have to be taken into account. Finally, genomic and proteomic tools will permit to study host influences on viral protein expression, or host specific viral immune evasion mechanisms [45], which will also affect the epitope repertoire in a species specific manner.
###end p 52
###begin p 53
###xml 71 77 <span type="species:ncbi:10090">murine</span>
###xml 154 159 <span type="species:ncbi:10090">mouse</span>
###xml 164 169 <span type="species:ncbi:9606">human</span>
###xml 220 226 <span type="species:ncbi:10090">murine</span>
###xml 356 361 <span type="species:ncbi:9606">human</span>
###xml 366 372 <span type="species:ncbi:10090">murine</span>
In conclusion, our detailed analysis of the binding specificity of the murine transporters allows for a sensitive comparison between peptide selection by mouse and human TAP, and demonstrates that epitopes recognized by murine CTLs are selected for increased TAP affinity. This work provides a key step towards the complete and differential description of human and murine antigen processing events.
###end p 53
###begin title 54
Materials and Methods
###end title 54
###begin title 55
###xml 54 60 <span type="species:ncbi:10090">murine</span>
Preparation of insect cell microsomes over-expressing murine TAP complexes
###end title 55
###begin p 56
###xml 640 641 631 632 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 684 685 675 676 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 906 910 897 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-vanEndert1">[20]</xref>
###xml 85 90 <span type="species:ncbi:9606">human</span>
###xml 136 142 <span type="species:ncbi:10090">murine</span>
Microsomes were prepared precisely as described previously for microsomes expressing human TAP. Briefly, full-length cDNAs encoding the murine TAP transporters were amplified from plasmids pFM370.1 and pFM372.3 (kindly provided by Frank Momburg), sequenced, and inserted as XbaI/NotI or BamhI/XbaI fragments, respectively, into the baculovirus transfer plasmid pVL1393, and recombinant viruses were produced by co-transfection of BaculoGoldtrade mark (Pharmingen) linearized baculovirus DNA together with the plasmids into Sf9 cells, followed by plaque assays and isolation of clones containing TAP DNA. For production of microsomes, 175 cm2 cell culture flasks each containing 5-8x106 Sf9 cells were infected at a multiplicity of infection of 3 with high titer viral supernatant. Three days later, cells were harvested, broken up in a Douncer, and fractionated using a sucrose step gradient, as described [20]. One flask of infected cells yielded on average 1 ml of microsome solution.
###end p 56
###begin title 57
Binding Assay
###end title 57
###begin p 58
###xml 28 34 28 34 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002402-g001">Fig. 1</xref>
###xml 56 59 56 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 174 178 174 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-vanEndert1">[20]</xref>
###xml 517 518 499 500 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 653 654 635 636 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1610 1612 1571 1573 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 1669 1671 1630 1632 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 1709 1711 1670 1672 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
The Scatchard plot shown in Fig. 1 was carried out with 125I-labeled reporter peptide RRYNASTEL, using exactly the same conditions as in the Scatchard plot analysis shown in [20]. The fluorescence polarization assay was carried out entirely at 4degreesC according to the following protocol. Peptides were obtained at approximately80% purity (Pepscan or Sigma-Genosys); peptide purity was controlled by HPLC, and identity verified by mass spectrometry. Peptide stocks were prepared at 10 mM in pure DMSO (50% DMSO in H2O for peptides with cysteines). Serial dilutions of test peptides were prepared in assay buffer (PBS with 1 mM dithiotreitol, 2 mM MgCl2 and 0.1% BSA), such that molar excesses relative to reporter peptide between 0.1x and 1000x could be tested. Dilutions of test peptides and reporter peptide (final concentration 20 nM) were added to black flat bottom 96-well plates (FluoroNunctrade mark, Nunc) in a total volume of 150 microl. Then 10 microl of microsomes, diluted to 50 microl in assay, buffer, was added, and fluorescence polarization immediately read using a Mithras LB940 microplate reader (Berthold, Thoiry, France). Unlabeled reporter peptide R9L was included in each assay as competitor to allow for normalization of data between different assays. Specific binding was determined as the difference between the polarization (mP) reading in the absence of competitor to the reading in the presence of a 1000-fold excess of unlabeled reporter peptide. The molar excess of the test peptide required for inhibiting 50% of specific binding of the reporter peptide was then determined (IC50). Assay results were finally expressed as ratio, i.e. IC50 of the test peptide divided by the IC50 of the unlabeled reporter peptide, in order to normalize results among different assays. Each peptide was tested in at least two independent assays; if the two results diverged by more than 25 percent, additional assays were performed. The final result corresponds to the mean of all validated assay results.
###end p 58
###begin title 59
Removal of Outliers
###end title 59
###begin p 60
###xml 206 212 <span type="species:ncbi:10090">murine</span>
A total of five peptides with the sequences ILMIFISSFL, AFILGIIITV, LMYIFAAL, MIVAWFLLL and WAIINTIYF were removed from the dataset. For each of these peptides, relatively weak or no competitive binding to murine TAP could be determined, even though their sequence strongly suggests them to be at least reasonable binders. At the same time, these peptides are very hydrophobic and therefore likely to have problems with solubility. This would result in them being classified as poor binders in the assay we employed, which is the basis for their removal.
###end p 60
###begin title 61
SMMBP Method
###end title 61
###begin p 62
###xml 153 157 153 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Peters1">[32]</xref>
###xml 159 163 159 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Peters2">[46]</xref>
###xml 585 589 585 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Sidney1">[47]</xref>
###xml 538 543 <span type="species:ncbi:9606">human</span>
###xml 545 555 <span type="species:ncbi:9598">chimpanzee</span>
###xml 570 575 <span type="species:ncbi:10090">mouse</span>
Peptide binding predictions for TAP and MHC-I molecules were carried out using the method SMM-BP (manuscript in preparation), an improved version of SMM [32], [46] that includes a Bayesian Prior (BP). Briefly, this method adds prior knowledge of amino acid similarities to the matrix determination process, by including a general amino acid binding covariance matrix. This covariance matrix was determined directly from a set of 180 randomized peptide libraries of length nine with measured binding affinities of to 24 MHC-I alleles from human, chimpanzee, macaque, and mouse (compare [47]). The SMM-BP method optimizes a scoring matrix such that the squared differences between measured and predicted binding affinity values are minimized, which corresponds to maximizing the likelihood of observing these measurements giving the prediction matrix and assuming a normal distribution of differences between predicted and measured values. The prior probability of the scoring matrix is calculated directly from the amino acid covariance matrix, which assumes that the scoring matrix follows the same Multivariate normal distribution. The final matrix is calculated following Bayes' Theorem by maximizing the product of the probabilities of likelihood and prior.
###end p 62
###begin title 63
T cell epitope dataset
###end title 63
###begin p 64
###xml 42 46 42 46 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Kotturi1">[42]</xref>
###xml 48 52 48 52 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002402-Moutaftsi1">[43]</xref>
###xml 520 521 516 517 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 524 525 520 521 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 528 529 524 525 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 532 533 528 529 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 538 539 534 535 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 711 712 707 708 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 180 184 <span type="species:ncbi:10090">mice</span>
###xml 204 208 <span type="species:ncbi:11623?0.9953846153846154">LCMV</span>
###xml 265 269 <span type="species:ncbi:10090">mice</span>
###xml 359 365 <span type="species:ncbi:10090">murine</span>
###xml 746 750 <span type="species:ncbi:10090">mice</span>
The epitope dataset used were taken from ([42], [43] and Oseroff et al, manuscript submitted). The epitope mapping in the three studies was performed as follows: C57BL/6 or Balb/c mice were infected with LCMV Armstrong or VACV WR. Eight to ten days post infection, mice were sacrificed, and splenocytes were taken. The cells were tested directly ex vivo in a murine IFN-gamma ELISPOT assays for responses against peptide pulsed target cells. The tested peptides were selected by their predicted ability to bind the H-2 Db, Dd, Kb, Kd or Ld molecules. Responses were measured in triplicate, and experiments repeated at least twice. Peptides that consistently gave responses twice above background and with SFC/106>20 were considered positive. The mice purchased from The Jackson Laboratory and maintained at the La Jolla Institute for Allergy and Immunology facility (San Diego, CA) following National Institutes of Health guidelines and Institutional Animal Care and Use Committee approved animal protocols.
###end p 64
###begin title 65
Supporting Information
###end title 65
###begin p 66
###xml 24 30 <span type="species:ncbi:10090">Murine</span>
Experimentally Measured Murine TAP Binding Affinities for the Peptides.
###end p 66
###begin p 67
(0.04 MB XLS)
###end p 67
###begin p 68
Click here for additional data file.
###end p 68
###begin p 69
###xml 41 47 <span type="species:ncbi:10090">murine</span>
###xml 100 106 <span type="species:ncbi:10090">murine</span>
We would like to thank Frank Momburg for murine TAP plasmids and John Monaco for antibodies against murine TAP proteins. Kirin number 979.
###end p 69
###begin title 70
References
###end title 70
###begin article-title 71
Producing nature's gene-chips: the generation of peptides for display by MHC class I molecules.
###end article-title 71
###begin article-title 72
T cell responses to influenza virus infection: effector and memory cells.
###end article-title 72
###begin article-title 73
Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections.
###end article-title 73
###begin article-title 74
###xml 47 64 <span type="species:ncbi:11103">hepatitis C virus</span>
Adaptive immune responses in acute and chronic hepatitis C virus infection.
###end article-title 74
###begin article-title 75
###xml 81 103 <span type="species:ncbi:1639">Listeria monocytogenes</span>
Direct sequence identification and kinetic analysis of an MHC class I-restricted Listeria monocytogenes CTL epitope.
###end article-title 75
###begin article-title 76
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 79 105 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis.
###end article-title 76
###begin article-title 77
###xml 55 73 <span type="species:ncbi:781">Rickettsia conorii</span>
Identification of CD8 T-lymphocyte epitopes in OmpB of Rickettsia conorii.
###end article-title 77
###begin article-title 78
###xml 20 25 <span type="species:ncbi:9606">human</span>
###xml 91 124 <span type="species:ncbi:90370">Salmonella enterica serovar Typhi</span>
Identification of a human HLA-E-restricted CD8+ T cell subset in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine.
###end article-title 78
###begin article-title 79
###xml 80 88 <span type="species:ncbi:9606">patients</span>
Enrichment of functional CD8 memory T cells specific for MUC1 in bone marrow of patients with multiple myeloma.
###end article-title 79
###begin article-title 80
Autoreactive CD8 T cells in organ-specific autoimmunity: emerging targets for therapeutic intervention.
###end article-title 80
###begin article-title 81
Immune epitope mapping in the post-genomic era: lessons for vaccine development.
###end article-title 81
###begin article-title 82
###xml 112 127 <span type="species:ncbi:10090">transgenic mice</span>
Epitope-driven TB vaccine development: a streamlined approach using immuno-informatics, ELISpot assays, and HLA transgenic mice.
###end article-title 82
###begin article-title 83
###xml 12 27 <span type="species:ncbi:10090">transgenic mice</span>
HLA class I transgenic mice: development, utilisation and improvement.
###end article-title 83
###begin article-title 84
An essential role for tripeptidyl peptidase in the generation of an MHC class I epitope.
###end article-title 84
###begin article-title 85
A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation.
###end article-title 85
###begin article-title 86
Quantitating protein synthesis, degradation, and endogenous antigen processing.
###end article-title 86
###begin article-title 87
Quantifying recruitment of cytosolic peptides for HLA class I presentation: impact of TAP transport.
###end article-title 87
###begin article-title 88
Peptide size selection by the major histocompatibility complex-encoded peptide transporter.
###end article-title 88
###begin article-title 89
###xml 47 52 <span type="species:ncbi:10090">mouse</span>
Peptide length and sequence specificity of the mouse TAP1/TAP2 translocator.
###end article-title 89
###begin article-title 90
A sequential model for peptide binding and transport by the transporters associated with antigen processing.
###end article-title 90
###begin article-title 91
The ER aminopeptidase, ERAP1, trims precursors to lengths of MHC class I peptides by a "molecular ruler" mechanism.
###end article-title 91
###begin article-title 92
###xml 30 35 <span type="species:ncbi:9606">human</span>
Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum.
###end article-title 92
###begin article-title 93
###xml 40 43 <span type="species:ncbi:9606">man</span>
ABC transporters: from microorganism to man.
###end article-title 93
###begin article-title 94
Powering the peptide pump: TAP crosstalk with energetic nucleotides.
###end article-title 94
###begin article-title 95
Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter.
###end article-title 95
###begin article-title 96
Export of antigenic peptides from the endoplasmic reticulum intersects with retrograde protein translocation through the Sec61p channel.
###end article-title 96
###begin article-title 97
Trimming of TAP-translocated peptides in the endoplasmic reticulum and in the cytosol during recycling.
###end article-title 97
###begin article-title 98
Cutting edge: HLA-B27 acquires many N-terminal dibasic peptides: coupling cytosolic peptide stability to antigen presentation.
###end article-title 98
###begin article-title 99
The rational design of TAP inhibitors using peptide substrate modifications and peptidomimetics.
###end article-title 99
###begin article-title 100
Substrate selection by transporters associated with antigen processing occurs during peptide binding to TAP.
###end article-title 100
###begin article-title 101
###xml 34 39 <span type="species:ncbi:9606">human</span>
The peptide-binding motif for the human transporter associated with antigen processing.
###end article-title 101
###begin article-title 102
Identifying MHC class I epitopes by predicting the TAP transport efficiency of epitope precursors.
###end article-title 102
###begin article-title 103
Peptide translocation by variants of the transporter associated with antigen processing.
###end article-title 103
###begin article-title 104
###xml 53 58 <span type="species:ncbi:9606">human</span>
###xml 60 65 <span type="species:ncbi:10090">mouse</span>
###xml 70 73 <span type="species:ncbi:10116">rat</span>
Selectivity of MHC-encoded peptide transporters from human, mouse and rat.
###end article-title 104
###begin article-title 105
Substrate specificity of allelic variants of the TAP peptide transporter.
###end article-title 105
###begin article-title 106
###xml 36 39 <span type="species:ncbi:10116">rat</span>
###xml 41 46 <span type="species:ncbi:10090">mouse</span>
###xml 51 56 <span type="species:ncbi:9606">human</span>
Analysis of the fine specificity of rat, mouse and human TAP peptide transporters.
###end article-title 106
###begin article-title 107
###xml 46 51 <span type="species:ncbi:9606">human</span>
Relationship between peptide selectivities of human transporters associated with antigen processing and HLA class I molecules.
###end article-title 107
###begin article-title 108
Recognition principle of the TAP transporter disclosed by combinatorial peptide libraries.
###end article-title 108
###begin article-title 109
Sensitive quantitative predictions of peptide-MHC binding by a 'Query by Committee' artificial neural network approach.
###end article-title 109
###begin article-title 110
Empirical evaluation of a dynamic experiment design method for prediction of MHC class I-binding peptides.
###end article-title 110
###begin article-title 111
Peptide selection by MHC-encoded TAP transporters.
###end article-title 111
###begin article-title 112
###xml 28 62 <span type="species:ncbi:11623">lymphocytic choriomeningitis virus</span>
The CD8+ T-cell response to lymphocytic choriomeningitis virus involves the L antigen: uncovering new tricks for an old virus.
###end article-title 112
###begin article-title 113
###xml 66 72 <span type="species:ncbi:10090">murine</span>
###xml 99 113 <span type="species:ncbi:10245">vaccinia virus</span>
A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus.
###end article-title 113
###begin article-title 114
Distinct functions of tapasin revealed by polymorphism in MHC class I peptide loading.
###end article-title 114
###begin article-title 115
Mini-review: Presentation of pathogen-derived antigens in vivo.
###end article-title 115
###begin article-title 116
Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method.
###end article-title 116
###begin article-title 117
###xml 59 69 <span type="species:ncbi:9598">chimpanzee</span>
Characterization of the peptide-binding specificity of the chimpanzee class I alleles A 0301 and A 0401 using a combinatorial peptide library.
###end article-title 117
###begin p 118
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 118
###begin p 119
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by the National Institutes of Health contract HHSN26620040006C to AS and BP, PSWRCE grant U54 AI065359 to BP, and grant LSHB-CT-2003-503231 (Genomes to Vaccines) of the European Commission to PvE.
###end p 119

